Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Other Gross PP&E Adjustments (2017 - 2026)

Organogenesis Holdings has reported Other Gross PP&E Adjustments over the past 9 years, most recently at $79.2 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 0.83% year-over-year to $79.2 million; the TTM value through Dec 2025 reached $79.2 million, up 0.83%, while the annual FY2025 figure was $79.2 million, 0.83% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $79.2 million at Organogenesis Holdings, up from $73.8 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $116.8 million in Q2 2023 and troughed at -$23.0 million in Q2 2024.
  • A 5-year average of $64.7 million and a median of $72.4 million in 2021 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 119.66% in 2024 and later surged 415.95% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $39.6 million in 2021, then surged by 38.97% to $55.1 million in 2022, then plummeted by 46.48% to $29.5 million in 2023, then soared by 166.54% to $78.5 million in 2024, then grew by 0.83% to $79.2 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for ORGO at $79.2 million in Q4 2025, $73.8 million in Q3 2025, and $72.6 million in Q2 2025.